Dynamic contrast-enhanced magnetic resonance for the monitoring of neoadjuvant chemoradiation therapy in rectal adenocarcinoma: initial experience with 20 patients

نویسندگان

  • G. Petralia
  • G. Castellazzi
  • P. Summers
  • R. Di Filippi
  • M. Pasin
  • M. G. Zampino
  • M. Leonardi
  • A. Chiappa
  • S. Viotti
  • L. Bonello
  • M. Bellomi
چکیده

G. Petralia, G. Castellazzi, P. Summers, R. Di Filippi, M. Pasin, M. G. Zampino, M. Leonardi, A. Chiappa, S. Viotti, L. Bonello, and M. Bellomi Radiology, Istituto Europeo di Oncologia, Milan, Lombardia, Italy, Struttura Complessa di Radiologia/Diagnostica per immagini, Istituto Neurologico IRCCSFondazione Casimiro Mondino, Pavia, Lombardia, Italy, Medical Care Unit, Department of Medicine, Istituto Europeo di Oncologia, Milan, Lombardia, Italy, Radiotherapy, Istituto Europeo di Oncologia, Milan, Lombardia, Italy, General and Laparoscopic Surgery, Istituto Europeo di Oncologia, Milan, Lombardia, Italy

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

New drug in neoadjuvant chemoradiation for rectal cancer

Background: In recent years, neoadjuvant chemoradiation and subsequent surgical resection with total mesorectal excision has been shown to increase local control with decreased toxicity. Neoadjuvant chemoradiotherapy is the standard treatment for locally advanced rectal cancer. In this study we evaluated the efficacy a cox-2 inhibitor on pathologic response, sphincter preservation and acute tox...

متن کامل

Comparison of 5FU-base Chemoradiation with and without Eloxatin on Pathologic Complete Response in Neoadjuvant Chemoradiation of Rectal cancer

  Background and Objectives: To compare pathologic complete response (pCR) in patients with advanced rectal cancer receiving neoadjuvant chemoradiotherapy (NACT) by 5-FU or Xeloda (capecitabine) with and without Eloxatin (oxaloplatin injection). Materials and Methods: Seventy-five consecutive patients with the diagnosis of advanced rectal adenocarcinoma were included. Two basic chemotherapy r...

متن کامل

سلکوکسیب همراه با کمورادیوتراپی نئوادجوانت در بیماران مبتلا به آدنوکارسینوم رکتوم مرحله II و III

Background: Colorectal cancer is the third common cancer world wide and the forth in Iran. Neoadjuvant chemoradiotherapy is the standard treatment for locally advanced rectal cancer. In this study we evaluate the efficacy a cox-2 inhibitor on pathologic response, sphincter preservation and acute toxicity during neoadjuvant chemoradiation. Methods: Thirty-six patients that have adenocarcinoma o...

متن کامل

Effect of Bias in Contrast Agent Concentration Measurement on Estimated Pharmacokinetic Parameters in Brain Dynamic Contrast-Enhanced Magnetic Resonance Imaging Studies

Introduction: Pharmacokinetic (PK) modeling of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is widely applied in tumor diagnosis and treatment evaluation. Precision analysis of the estimated PK parameters is essential when they are used as a measure for therapy evaluation or treatment planning. In this study, the accuracy of PK parameters in brain DCE...

متن کامل

Safe distal margin resection in patients with low rectal cancer undergoing neoadjuvant chemoradiation

Background: Colorectal carcinoma is the third most common cause of death in Iran. This study was performed in order to determine the appropriate distal clearance margin (DCM) for resection of rectal cancer in patients who undergo neoadjuvant chemoradiotherapy for sphincter preserving procedure. Materials and Methods: This was a cross-sectional study conducted in Shahid Faghihi Hospital of Shira...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2009